HER2 Proven Diagnostic Accuracy

Since 1988, laboratories around the world have relied on the diagnostic accuracy of Dako HER2 testing for breast cancer. Now new hope is given for patients with gastric cancer. A recent clinical study shows that HercepTest™ and HER2 FISH pharmDx™ Kit accurately identify patients with gastric cancer who may benefit from trastuzumab treatment.*

HER2 treatment now targets both patients with breast and gastric cancer indications.

HER2 Gastric

*Lancet 2010; 376:687-07

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.


Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement



Get in Touch with Dako in Finland

  • Pathology Products
    Algol Diagnostics Oy

    orders@algoldiagnostics.fi
    +358 9 50 991
    +358 9 595 006

    P.O. Box 13
    FI-02611 Espoo

  • Flow Cytometry Products and Specific Proteins
    Electra-Box Diagnostica Oy

    +358 (0)9 7244330
    +358 (0)9 7244331

    Lyhtytie 8
    00750 Helsinki

Detailed contact information

Submit an Inquiry

How would you like us to follow up?


Your session expired

You have been logged out. Log in again to retrieve your Cart.